Veterinary Medicines

Therios 300 mg palatable tablets for dogs

Authorised
  • Cefalexin monohydrate
Download as PDF

Product identification

Medicine name:
Therios 300 mg palatable tablets for dogs
THERIOS
Active substance:
  • Cefalexin monohydrate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Cefalexin monohydrate
    315.54
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01DB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Available in:
  • Italy
Package description:
  • Polyvinylchloride blister heat sealed with an aluminium cover foil.Pack sizes:Cardboard box with 20 blisters of 10 tablets
  • Polyvinylchloride blister heat sealed with an aluminium cover foil.Pack sizes:Cardboard box with 1 blister of 10 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Salute Animale S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • CEVA Santé Animale
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 104316
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0516/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Finland
  • Germany
  • Greece
  • Hungary
  • Italy
  • Luxembourg
  • Netherlands
  • Portugal
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 15/12/2024
Download
Italian (PDF)
Published on: 10/04/2024
Download